Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-27 @ 3:31 AM
Study NCT ID:
NCT02911857
Status:
COMPLETED
Last Update Posted:
2018-08-20
First Post:
2016-09-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CACZ885N2301E2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None